Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.198 EUR | +2.17% | +0.36% | +22.42% |
29/05 | Sales in Milan; but Philogen is at annual peak | AN |
29/05 | Milan opens in red; new grits for MPS | AN |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+22.42% | 3.51B | - | ||
+17.58% | 572B | C+ | ||
+17.17% | 302B | C+ | ||
+15.71% | 252B | C+ | ||
+20.20% | 206B | C | ||
+19.14% | 182B | B- | ||
+24.16% | 168B | B- | ||
+9.58% | 163B | C+ | ||
+9.76% | 153B | B- | ||
-10.40% | 138B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BPSO Stock
- 593 Stock
- Ratings Banca Popolare di Sondrio S.p.A